[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 246
Citations 0
Capitol Health Call
March 10, 2015

Outdated Regulatory Processes Delay New Treatments, Senators Say

JAMA. 2015;313(10):1004. doi:10.1001/jama.2015.0940

The United States’ global edge in medical innovation is slipping because the discovery and development process takes too much time and money, according to a report released January 29 by Sen Lamar Alexander (R, Tenn) and Sen Richard Burr (R, NC) (http://1.usa.gov/162Tm36).

One of the main reasons for the delay in getting treatments to patients is an overburdened FDA that can’t keep up with the fast pace of biomedical innovation, Alexander and Burr said in the report.

First Page Preview View Large
First page PDF preview
First page PDF preview